Volume 5, Number 5, September-October 2008

Lipid Modification in Primary Prevention – Treatment not Target
Jan Procter-King

The NICE lipid modification guideline, published in May this year, covered both primary and secondary prevention of CVD. This article will look briefly at the principles of this guideline in relation to primary prevention and then go further to highlight the key issues regarding statin prescribing for people established to be at high cardiovascular risk.

View full PDF article (open in new window)
Email this article